These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28347615)

  • 41. Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12.
    Landouré G; Zhu PP; Lourenço CM; Johnson JO; Toro C; Bricceno KV; Rinaldi C; Meilleur KG; Sangaré M; Diallo O; Pierson TM; Ishiura H; Tsuji S; Hein N; Fink JK; Stoll M; Nicholson G; Gonzalez MA; Speziani F; Dürr A; Stevanin G; Biesecker LG; ; Accardi J; Landis DM; Gahl WA; Traynor BJ; Marques W; Züchner S; Blackstone C; Fischbeck KH; Burnett BG
    Hum Mutat; 2013 Oct; 34(10):1357-60. PubMed ID: 23857908
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dominant mitochondrial membrane protein-associated neurodegeneration (MPAN) variants cluster within a specific C19orf12 isoform.
    Rickman OJ; Salter CG; Gunning AC; Fasham J; Voutsina N; Leslie JS; McGavin L; Cross HE; Posey JE; Akdemir ZC; Jhangiani SN; Lupski JR; Baple EL; Crosby AH
    Parkinsonism Relat Disord; 2021 Jan; 82():84-86. PubMed ID: 33260061
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Novel Deletion Mutation of Exon 2 of the C19orf12 Gene in an Omani Family with Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN).
    Al Macki N; Al Rashdi I
    Oman Med J; 2017 Jan; 32(1):66-68. PubMed ID: 28042406
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel case of neurodegeneration with brain iron accumulation 4 (NBIA4) caused by a pathogenic variant affecting splicing.
    Sparber P; Marakhonov A; Filatova A; Sharkova I; Skoblov M
    Neurogenetics; 2018 Dec; 19(4):257-260. PubMed ID: 30392167
    [TBL] [Abstract][Full Text] [Related]  

  • 45. C19orf12 and FA2H mutations are rare in Italian patients with neurodegeneration with brain iron accumulation.
    Panteghini C; Zorzi G; Venco P; Dusi S; Reale C; Brunetti D; Chiapparini L; Zibordi F; Siegel B; Garavaglia B; Simonati A; Bertini E; Nardocci N; Tiranti V
    Semin Pediatr Neurol; 2012 Jun; 19(2):75-81. PubMed ID: 22704260
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Downregulation of
    Mignani L; Zizioli D; Borsani G; Monti E; Finazzi D
    Front Cell Dev Biol; 2020; 8():596069. PubMed ID: 33425903
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation.
    Hartig MB; Hörtnagel K; Garavaglia B; Zorzi G; Kmiec T; Klopstock T; Rostasy K; Svetel M; Kostic VS; Schuelke M; Botz E; Weindl A; Novakovic I; Nardocci N; Prokisch H; Meitinger T
    Ann Neurol; 2006 Feb; 59(2):248-56. PubMed ID: 16437574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new Turkish family with homozygous FBXO7 truncating mutation and juvenile atypical parkinsonism.
    Yalcin-Cakmakli G; Olgiati S; Quadri M; Breedveld GJ; Cortelli P; Bonifati V; Elibol B
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1248-52. PubMed ID: 25085748
    [TBL] [Abstract][Full Text] [Related]  

  • 49. C19orf12 mutation leads to a pallido-pyramidal syndrome.
    Kruer MC; Salih MA; Mooney C; Alzahrani J; Elmalik SA; Kabiraj MM; Khan AO; Paudel R; Houlden H; Azzedine H; Alkuraya F
    Gene; 2014 Mar; 537(2):352-6. PubMed ID: 24361204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neurodegeneration associated with genetic defects in phospholipase A(2).
    Gregory A; Westaway SK; Holm IE; Kotzbauer PT; Hogarth P; Sonek S; Coryell JC; Nguyen TM; Nardocci N; Zorzi G; Rodriguez D; Desguerre I; Bertini E; Simonati A; Levinson B; Dias C; Barbot C; Carrilho I; Santos M; Malik I; Gitschier J; Hayflick SJ
    Neurology; 2008 Oct; 71(18):1402-9. PubMed ID: 18799783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generation of two human iPSC lines, HMGUi004-A and FINCBi004-A, from fibroblasts of MPAN patients carrying pathogenic recessive mutations in the gene C19orf12.
    Zanuttigh E; Rusha E; Peron C; Brunetti D; Zorzi G; Pertek A; Nteli P; Winkelmann J; Tiranti V; Iuso A
    Stem Cell Res; 2023 Oct; 72():103197. PubMed ID: 37689041
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinicopathological variability in neurodegeneration with brain iron accumulation.
    Vincze A; Kapás I; Molnar MJ; Kovács GG
    Ideggyogy Sz; 2010 Mar; 63(3-4):129-35. PubMed ID: 20405671
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SPG43 and ALS-like syndrome in the same family due to compound heterozygous mutations of the C19orf12 gene: a case description and brief review.
    Remiche G; Vandernoot I; Sadeghi-Meibodi N; Desmyter L
    Neurogenetics; 2021 Mar; 22(1):95-101. PubMed ID: 33394258
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Case Report: Identification of a
    Yang Y; Zhang S; Yang W; Wei T; Hao W; Cheng T; Wang J; Dong W; Qian N
    Front Genet; 2022; 13():852374. PubMed ID: 35432442
    [No Abstract]   [Full Text] [Related]  

  • 55. Mutations in C19orf12 and intronic repeat expansions in C9orf72 not observed in Iranian Parkinson's disease patients.
    Alavi A; Malakouti Nejad M; Shahidi G; Elahi E
    Neurobiol Aging; 2017 Jun; 54():214.e11-214.e12. PubMed ID: 28365006
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations.
    Hayflick SJ; Hartman M; Coryell J; Gitschier J; Rowley H
    AJNR Am J Neuroradiol; 2006; 27(6):1230-3. PubMed ID: 16775270
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mitochondrial membrane protein-associated neurodegeneration.
    Deutschländer A; Konno T; Ross OA
    Parkinsonism Relat Disord; 2017 Jun; 39():1-3. PubMed ID: 28359667
    [No Abstract]   [Full Text] [Related]  

  • 58. β-Propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation.
    Hayflick SJ; Kruer MC; Gregory A; Haack TB; Kurian MA; Houlden HH; Anderson J; Boddaert N; Sanford L; Harik SI; Dandu VH; Nardocci N; Zorzi G; Dunaway T; Tarnopolsky M; Skinner S; Holden KR; Frucht S; Hanspal E; Schrander-Stumpel C; Mignot C; Héron D; Saunders DE; Kaminska M; Lin JP; Lascelles K; Cuno SM; Meyer E; Garavaglia B; Bhatia K; de Silva R; Crisp S; Lunt P; Carey M; Hardy J; Meitinger T; Prokisch H; Hogarth P
    Brain; 2013 Jun; 136(Pt 6):1708-17. PubMed ID: 23687123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of Autophagy as a Functional Target Suitable for the Pharmacological Treatment of Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN) In Vitro.
    Zanuttigh E; Derderian K; Güra MA; Geerlof A; Di Meo I; Cavestro C; Hempfling S; Ortiz-Collazos S; Mauthe M; Kmieć T; Cammarota E; Panzeri MC; Klopstock T; Sattler M; Winkelmann J; Messias AC; Iuso A
    Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurodegeneration with brain iron accumulation: clinical, radiographic and genetic heterogeneity and corresponding therapeutic options.
    Clement F; Devos D; Moreau C; Coubes P; Destee A; Defebvre L
    Acta Neurol Belg; 2007 Mar; 107(1):26-31. PubMed ID: 17569231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.